LCZ696 CAS 936623-90-4
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
936623-90-4
Name
LCZ696
Synonyms
LZC696;Entresto;
LCZ696 Entresto;
LCZ696 interMediate;
Valsartan/sacubitril;
lcz696/Valsartan/sacubitril;
Sacubitril-Valsartan complex;
Valsartan-sacubitril(LCZ696);
Sacubitril mixture with Valsartan;
Cocrystal of Sacubitril and Valsartan;
Trisodium [3-(( 1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1- butylcarbamoyl)propionate-(S)-3′-methyl-2′-(pentanoyl{2″-(tetrazol-5-ylate )biphenyl-4′-ylmethyl }amino )butyrate ]hemipentahydrate
Molecular Structure
SMILES
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[nH]nnn3)[C@@H](C(C)C)C(=O)O.CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[nH]nnn3)[C@@H](C(C)C)C(=O)O.CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)O.CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)c2ccccc2)NC(=O)CCC(=O)O.O.O.O.O.O.[NaH].[NaH].[NaH].[NaH].[NaH].[NaH]
StdInChI
InChI=1S/2C24H29N5O3.2C24H29NO5.6Na.5H2O.6H/c2*1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23;2*1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;;;;;;;;;;;;;;;;;/h2*6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28);2*4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);;;;;;;5*1H2;;;;;;/t2*22-;2*17-,21+;;;;;;;;;;;;;;;;;/m0011……………../s1
StdInChIKey
ZBGURHOZEKISEC-VDKBMKBSSA-N
Molecular Formula
2(C24H29N5O3).2(C24H29NO5).5(H2O).6Na
Molecular Weight
1922.06
Properties
Appearance
Off-white to white block powder solid
Safety Data
WGK Germany
3
Specifications and Other Information of Our LCZ696 CAS 936623-90-4
Standard
Enterprise standard
Identification Methods
HPLC
Purity
≥99.5%
Water
4.00%-5.90%
LARGEST SINGLE IMPURITY
<0.1%
LCZ-1-IMP4
<0.1%
LCZ-2-IMP5
<0.5%
LCZ-2-IMP4
<0.1%
LCZ-2-IMP6
<0.1%
LCZ-2-IMP9
<0.1%
TOTAL IMPURITIES
<0.5%
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
LCZ696 is a drug for treating heart failure.
General View of Documents
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/lcz696-cas-936623-90-4/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/lcz696-cas-936623-90-4/